Themis Medicare informs about company updates

22 Aug 2018 Evaluate

Themis Medicare has informed that the Company’s Haridwar Plant has been granted a Certificate by European Union - Good Manufacturing Practice (EU-GMP) for Company’s oral and topical manufacturing sections. With this, the Company can commercialise its products in the European Union (EU) countries. This certification will also give access to the Company to commercialise its products in the Pharmaceutical Inspection Co-operation Scheme (PICS) markets for Company’s products manufactured at Company’s State of-the-Art manufacturing facility at Haridwar.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

105.60 -0.70 (-0.66%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×